Author:
Doolan Padraig,Clynes Martin,Kennedy Susan,Mehta Jai Prakash,Crown John,O’Driscoll Lorraine
Publisher
Springer Science and Business Media LLC
Reference21 articles.
1. Ikeda H, Lethe B, Lehmann F et al (1997) Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor. Immunity 6:199–208
2. Epping MT, Wang L, Edel MJ, Carlee L, Hernandez M, Bernards R (2005) The human tumour antigen PRAME is a dominant repressor of retinoic acid receptor signaling. Cell 122:835–847
3. Epping MT, Bernards R (2006) A causal role for the human tumour antigen preferentially expressed antigen of melanoma in cancer. Cancer Res 66:10639–10642
4. Neumann E, Engelsberg A, Decker J et al (1998) Heterogeneous expression of the tumour-associated antigens RAGE-1, PRAME, and glycoprotein 75 in human renal cell carcinoma: candidates for T-cell-based immunotherapies? Cancer Res 58:4090–4095
5. Li CM, Guo M, Borczuk A et al (2002) Gene expression in Wilms’ tumour mimics the earliest committed stage in the metanephric mesenchymal-epithelial transition. Am J Pathol 160:2181–2190
Cited by
63 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献